The global cell separation market size was valued at over USD 3.6 billion in 2016 and is projected to grow at 18.6% over the forecast period. Increasing interest of biotechnology companies and scientists in cancer and stem cell research is a major factor boosting the growth of the market. Advanced cell isolation products deliver improved separation of biological molecules including proteins, nucleic acids, chromatin, protein complexes for subsequent analysis. Thus, the demand for these products is mounting, which is expected to support the cell isolation/cell separation market growth during the forecast period.
In addition, increasing demand for personalized medicine is another major factor propelling the industry growth. Personalized medicine is a type of medical therapy in which the treatment is customized for an individual patient. The cell separation techniques can be used in personalized medicine for early detection of disease, selection of appropriate treatment, and determining the prognosis of the therapy.
U.S. cell isolation market, by product, 2014 - 2025 (USD Million)
On the basis of product, the market is segmented into consumables and instruments. In 2016, consumables segment was the largest revenue-generating segment. Rising investment in research & development by biotechnology and biopharmaceutical companies is a key factor boosting the segment growth. Thus, the demand for cell separation consumables is also expected to remain high during the forecast period.
The instruments segment is projected to exhibit lucrative growth rate during the study period, due to product advancement. The technological advancement in instruments provides efficient cell separation in research, diagnostics, and therapeutics application. Thus, the industry for instruments is expected to showcase significant growth rate during the study period.
The human type segment is reported to have a major revenue share of the cell isolation market in 2016. The growing focus on cancer & human stem cell research; and wide application of isolated human cells in research, biopharmaceuticals development, and clinical trials are the major factors contributing to its highest share.
The animal type segment is expected to exhibit significant growth rate during the study period. The escalating focus of government and healthcare companies on new drug discovery and development drives the segment growth. The drug discovery and development involves the use of animal cells to examine preliminary toxicity, efficacy, and pharmacokinetics of a new drug molecule.
On the basis of technique, the report is segmented into centrifugation, surface marker, and filtration. In 2016, the centrifugation segment accounted for the largest share of the market, mainly due to the extensive application of this technique by research laboratories, academic institutes, biotechnology & biopharmaceutical companies, and cell banks.
Surface marker and filtration segment is expected to showcase significant growth during the forecast period. Product advancement and growing investment in manufacturing infrastructure by companies are prime factors endorsing the growth of this segment. The manufacturers are using advanced filtration systems surface marker for the research and production process to assure the better quality of the end product.
The biomolecule isolation segment is reported to have the highest revenue share in 2016. The growing focus on production of biopharmaceuticals including biosimilars, monoclonal antibodies, and recombinant proteins is the most predominant factor contributing to its highest share. Also, increasing government funding for new drug development propels industry growth.
Cancer and stem cell research segment is expected to exhibit lucrative growth during the study period. The rising investment in cell-based research by companies and research laboratories is a prime factor attributing to the growth of this segment. They are investing a large amount of money for cancer research owing to increasing incidence of cancer cases globally.
The research laboratories and institutes dominated the market in 2016 due to increased cancer and stem cells research. Also, the support of government for cell-based research propels the segment growth.
North America cell isolation market share, by end-use, 2016
The biotechnology & biopharmaceutical companies segment is also expected to have a significant share, owing to rising R&D investment by these companies for new product development. These companies are focusing on the R&D of protein therapeutics, monoclonal antibody, stem cells research, cryobanking, and cell-based assays development.
North America dominated the market globally in 2016. The well-developed research infrastructure and the presence of global biotechnology companies in North America have fueled the regional market. Moreover, the presence of advanced technology and large focus on drug discovery in this region drives the sector growth.
Asia Pacific is projected to showcase the highest growth during the forecast period owing to growing presence of clinical research organizations and biopharmaceutical companies in this region. The availability of a vast genome pool, less stringent regulations for drug development, and availability of skilled personnel in this region are some of the major factors responsible for the growth of the sector in this region.
Some of the key players in the market are Thermo Fisher Scientific, Inc.; Merck KGaA; BD Biosciences; Beckman Coulter, Inc.; Terumo BCT; GE Healthcare; STEMCELL Technologies Inc.; and Bio-Rad Laboratories, Inc. The major companies are undertaking various strategies initiatives, such as collaborations, mergers & acquisitions, new product launch, and regional expansion for serving the unmet needs of their customers.
New product development helps vendors to expand their product portfolio and gain maximum share in the sector. For instance, Thermo Scientific’s Medifuge is a benchtop centrifuge that is featured with a unique hybrid rotor and has interchangeable swing-out buckets and fixed-angle rotors to facilitate rapid & convenient applications on a single platform.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2017 - 2025
Revenue in USD Million and CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America & MEA
U.S., Canada, UK, Germany, Japan, India, China, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the cell separation market on the basis of product, cell type, technique, application, end-use, and region:
Product Outlook (Revenue, USD Million; 2014 - 2025)
Reagents, kits, media, and sera
Magnetic-activated cell separator systems
Type Outlook (Revenue, USD Million; 2014 - 2025)
Technique Outlook (Revenue, USD Million; 2014 - 2025)
Application Outlook (Revenue, USD Million; 2014 - 2025)
Research laboratories and institutes
Biotechnology and biopharmaceutical companies
Hospitals and diagnostic laboratories
Regional Outlook (Revenue, USD Million; 2014 - 2025)
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.